Literature DB >> 9925083

Systemic distribution of talc after intrapleural administration in rats.

E C Werebe1, R Pazetti, J R Milanez de Campos, P P Fernandez, V L Capelozzi, F B Jatene, F S Vargas.   

Abstract

STUDY
OBJECTIVES: Many reports have shown the efficacy of talc to induce an effective pleurodesis. However, there is little information about the side effects related to this sclerosing agent. The objective of this experimental study is to recognize the systemic distribution of talc after its instillation into the pleural space of rats.
DESIGN: Forty animals were assigned to receive talc through a catheter placed in a left minimal thoracotomy. They were randomly divided in two groups: group 1 received 20 mg of talc and group 2 received 10 mg in the same total volume of 1 mL of saline solution. Half of the animals in each group were killed 24 h and the other half 48 h after the procedure. BAL was collected and histologic sections of both lungs, chest wall, liver, kidneys, spleen, heart, and brain were examined. Crystals were tracked using polarized light and we have used a "birefringent particles index of deposition" in an attempt to quantify the amount or talc encountered in different organs.
RESULTS: Talc crystals were found in every organ of all animals studied (100%). There was no statistical difference either on the dose of talc used or in the time of death. The amount of talc was statistically different in the organs, which made us divagate about a route of absorption.
CONCLUSIONS: We conclude that there is a progressive deposition of talc particles in the organs examined after its administration into the pleural space of normal rats. This report suggests that there is a rapid absorption of talc through the pleural surface and that the systemic distribution thereafter is not dose related. Further studies are necessary to assess the amount of crystals and the clinical correlation to these findings.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9925083     DOI: 10.1378/chest.115.1.190

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

1.  Experimental validation of talc pleurodesis for carcinomatous pleuritis in an animal model.

Authors:  Yasunori Iwasaki; Shinzo Takamori; Masahiro Mitsuoka; Masaki Kashihara; Tatsuya Nishi; Daigo Murakami; Ryoichi Matsumoto; Hiroharu Mifune; Yuji Tajiri; Yoshito Akagi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-05-12

2.  Optimal management of malignant pleural effusions (results of CALGB 30102).

Authors:  Todd L Demmy; Lin Gu; Jack E Burkhalter; Eric M Toloza; Thomas A D'Amico; Susan Sutherland; Xiaofei Wang; Laura Archer; Linda J Veit; Leslie Kohman
Journal:  J Natl Compr Canc Netw       Date:  2012-08       Impact factor: 11.908

3.  Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.

Authors:  Carolyn M Dresler; Jemi Olak; James E Herndon; William G Richards; Ernest Scalzetti; Stewart B Fleishman; Kemp H Kernstine; Todd Demmy; David M Jablons; Leslie Kohman; Thomas M Daniel; George B Haasler; David J Sugarbaker
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

4.  Changes in the pleural cavity by pleurodesis using talc or OK-432: an experimental study.

Authors:  Fumihiko Muta; Shinzo Takamori; Toshihiro Matsuo; Yasunori Iwasaki; Koichi Yoshiyama; Kazuo Shirouzu
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

5.  Transforming growth factor beta(2) (TGF beta(2)) produces effective pleurodesis in sheep with no systemic complications.

Authors:  Y C Lee; K B Lane; R E Parker; D S Ayo; J T Rogers; R W Diters; P J Thompson; R W Light
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

6.  Management of recurrent malignant pleural effusion with chemical pleurodesis.

Authors:  Dalokay Kilic; Hadi Akay; Sevket Kavukçu; Hakan Kutlay; Ayten Kayi Cangir; Serkan Enön; Cem Kadilar
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 7.  Malignant pleural effusions: appropriate treatment approaches.

Authors:  Yener Aydin; Atila Turkyilmaz; Yavuz Selim Intepe; Atilla Eroglu
Journal:  Eurasian J Med       Date:  2009-12

8.  Comparison of side effects of oxytetracycline and talc pleurodesis: an experimental study.

Authors:  Alper Gözübüyük; Berkant Ozpolat; Ali Fuat Ciçek; Hasan Caylak; Orhan Yücel; Kuthan Kavaklı; Sedat Gürkök; Onur Genç
Journal:  J Cardiothorac Surg       Date:  2010-12-13       Impact factor: 1.637

9.  An update in the management of malignant pleural effusion.

Authors:  Dk Muduly; Svs Deo; Ts Subi; Aa Kallianpur; Nk Shukla
Journal:  Indian J Palliat Care       Date:  2011-05

10.  An observational study on safety and efficacy of povidone-iodine for pleurodesis in cancer patients.

Authors:  Ayush Makkar; Sanjeev Patni; Anjum Khan Joad; Kamal Kishor Lakhera
Journal:  South Asian J Cancer       Date:  2017 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.